APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endorphins

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Endorphins Market Outlook and Growth Opportunities 2026

31 December 2025195 pages

Choose your research edition.

Industry ResearchEndorphins Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Endorphins Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Endorphins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endorphins Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Endorphins Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Endorphins market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Endorphins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Endorphins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endorphins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Endorphins market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Endorphins market include Assertio Therapeutics Inc., Cipher Pharmaceuticals Inc., Egalet Corp., Endo International Plc, Lannett Co. Inc., Pfizer and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Endorphins market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Endorphins and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Endorphins sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Endorphins market size, projected growth trends, production technologies, key applications, and end-use industries.

Endorphins Segment by Company

Assertio Therapeutics Inc.

Cipher Pharmaceuticals Inc.

Egalet Corp.

Endo International Plc

Lannett Co. Inc.

Pfizer

Johnson & Johnson

Endorphins Segment by Type

Sigma-Endorphins

Gamma-Endorphins

Beta-Endorphins

Alpha-Endorphins

Endorphins Segment by Application

Institutional Pharmacies

Retail Pharmacies

Online Pharmacies

Endorphins Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Endorphins status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Endorphins market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Endorphins significant trends, drivers, influence factors in global and regions.

6. To analyze Endorphins competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endorphins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endorphins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endorphins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Endorphins market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Endorphins industry.

Chapter 3: Detailed analysis of Endorphins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Endorphins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Endorphins in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Endorphins Industry Trends Table 2. Endorphins Industry Drivers Table 3. Endorphins Industry Opportunities and Challenges Table 4. Endorphins Industry Restraints Table 5. Global Endorphins Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Endorphins Revenue Share by Company (2021-2026) Table 7. Global Endorphins Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Endorphins Sales Volume Share by Company (2021-2026) Table 9. Global Endorphins Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Endorphins Company Ranking, (2024-2026) & (USD Million) Table 11. Global Endorphins Key Company Manufacturing Base & Headquarters Table 12. Global Endorphins Company, Product Type & Application Table 13. Global Endorphins Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Endorphins by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Sigma-Endorphins Table 18. Significant Companies of Gamma-Endorphins Table 19. Significant Companies of Beta-Endorphins Table 20. Significant Companies of Alpha-Endorphins Table 21. Global Endorphins Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Endorphins Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Endorphins Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Endorphins Sales Volume Share by Type (2021-2026) Table 25. Global Endorphins Sales Volume Share by Type (2027-2032) Table 26. Global Endorphins Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Endorphins Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Endorphins Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Endorphins Sales Value Share by Type (2021-2026) Table 30. Global Endorphins Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Institutional Pharmacies Table 32. Significant Companies of Retail Pharmacies Table 33. Significant Companies of Online Pharmacies Table 34. Global Endorphins Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Endorphins Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Endorphins Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Endorphins Sales Volume Share by Application (2021-2026) Table 38. Global Endorphins Sales Volume Share by Application (2027-2032) Table 39. Global Endorphins Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Endorphins Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Endorphins Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Endorphins Sales Value Share by Application (2021-2026) Table 43. Global Endorphins Sales Value Share by Application (2027-2032) Table 44. Global Endorphins Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Endorphins Sales by Region (2021-2026) & (K Units) Table 46. Global Endorphins Sales Market Share by Region (2021-2026) Table 47. Global Endorphins Sales by Region (2027-2032) & (K Units) Table 48. Global Endorphins Sales Market Share by Region (2027-2032) Table 49. Global Endorphins Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Endorphins Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Endorphins Sales Value Share by Region (2021-2026) Table 52. Global Endorphins Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Endorphins Sales Value Share by Region (2027-2032) Table 54. Global Endorphins Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Endorphins Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Endorphins Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Endorphins Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Endorphins Sales by Country (2021-2026) & (K Units) Table 59. Global Endorphins Sales Market Share by Country (2021-2026) Table 60. Global Endorphins Sales by Country (2027-2032) & (K Units) Table 61. Global Endorphins Sales Market Share by Country (2027-2032) Table 62. Global Endorphins Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Endorphins Sales Value Market Share by Country (2021-2026) Table 64. Global Endorphins Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Endorphins Sales Value Market Share by Country (2027-2032) Table 66. Assertio Therapeutics Inc. Company Information Table 67. Assertio Therapeutics Inc. Business Overview Table 68. Assertio Therapeutics Inc. Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Assertio Therapeutics Inc. Endorphins Product Portfolio Table 70. Assertio Therapeutics Inc. Recent Development Table 71. Cipher Pharmaceuticals Inc. Company Information Table 72. Cipher Pharmaceuticals Inc. Business Overview Table 73. Cipher Pharmaceuticals Inc. Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Cipher Pharmaceuticals Inc. Endorphins Product Portfolio Table 75. Cipher Pharmaceuticals Inc. Recent Development Table 76. Egalet Corp. Company Information Table 77. Egalet Corp. Business Overview Table 78. Egalet Corp. Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Egalet Corp. Endorphins Product Portfolio Table 80. Egalet Corp. Recent Development Table 81. Endo International Plc Company Information Table 82. Endo International Plc Business Overview Table 83. Endo International Plc Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Endo International Plc Endorphins Product Portfolio Table 85. Endo International Plc Recent Development Table 86. Lannett Co. Inc. Company Information Table 87. Lannett Co. Inc. Business Overview Table 88. Lannett Co. Inc. Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Lannett Co. Inc. Endorphins Product Portfolio Table 90. Lannett Co. Inc. Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Pfizer Endorphins Product Portfolio Table 95. Pfizer Recent Development Table 96. Johnson & Johnson Company Information Table 97. Johnson & Johnson Business Overview Table 98. Johnson & Johnson Endorphins Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Johnson & Johnson Endorphins Product Portfolio Table 100. Johnson & Johnson Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Endorphins Distributors List Table 104. Endorphins Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Endorphins Product Image Figure 2. Global Endorphins Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endorphins Sales Value (2021-2032) & (US$ Million) Figure 4. Global Endorphins Sales (2021-2032) & (K Units) Figure 5. Global Endorphins Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Endorphins Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Sigma-Endorphins Image Figure 10. Gamma-Endorphins Image Figure 11. Beta-Endorphins Image Figure 12. Alpha-Endorphins Image Figure 13. Global Endorphins Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Endorphins Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Endorphins Sales Volume Share by Type (2021-2032) Figure 16. Global Endorphins Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Endorphins Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Endorphins Sales Value Share by Type (2021-2032) Figure 19. Institutional Pharmacies Image Figure 20. Retail Pharmacies Image Figure 21. Online Pharmacies Image Figure 22. Global Endorphins Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Endorphins Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Endorphins Sales Volume Share by Application (2021-2032) Figure 25. Global Endorphins Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Endorphins Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Endorphins Sales Value Share by Application (2021-2032) Figure 28. Global Endorphins Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Endorphins Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Endorphins Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Endorphins Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Endorphins Sales Value (2021-2032) & (US$ Million) Figure 33. North America Endorphins Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Endorphins Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Endorphins Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Endorphins Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Endorphins Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Endorphins Sales Value (2021-2032) & (US$ Million) Figure 39. South America Endorphins Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Endorphins Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Endorphins Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Endorphins Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Endorphins Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Endorphins Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Endorphins Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Endorphins Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Sigma-Endorphins
  • Gamma-Endorphins
  • Beta-Endorphins
  • Alpha-Endorphins
Applications
  • Institutional Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Companies covered
  • Assertio Therapeutics Inc.
  • Cipher Pharmaceuticals Inc.
  • Egalet Corp.
  • Endo International Plc
  • Lannett Co. Inc.
  • Pfizer
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Endorphins Sales Value (2021-2032)
  4. 1.2.2 Global Endorphins Sales Volume (2021-2032)
  5. 1.2.3 Global Endorphins Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Endorphins Market Dynamics
  1. 2.1 Endorphins Industry Trends
  2. 2.2 Endorphins Industry Drivers
  3. 2.3 Endorphins Industry Opportunities and Challenges
  4. 2.4 Endorphins Industry Restraints
3 Endorphins Market by Company
  1. 3.1 Global Endorphins Company Revenue Ranking in 2025
  2. 3.2 Global Endorphins Revenue by Company (2021-2026)
  3. 3.3 Global Endorphins Sales Volume by Company (2021-2026)
  4. 3.4 Global Endorphins Average Price by Company (2021-2026)
  5. 3.5 Global Endorphins Company Ranking (2024-2026)
  6. 3.6 Global Endorphins Company Manufacturing Base and Headquarters
  7. 3.7 Global Endorphins Company Product Type and Application
  8. 3.8 Global Endorphins Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Endorphins Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Endorphins Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Endorphins Market by Type
  1. 4.1 Endorphins Type Introduction
  2. 4.1.1 Sigma-Endorphins
  3. 4.1.2 Gamma-Endorphins
  4. 4.1.3 Beta-Endorphins
  5. 4.1.4 Alpha-Endorphins
  6. 4.2 Global Endorphins Sales Volume by Type
  7. 4.2.1 Global Endorphins Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Endorphins Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Endorphins Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Endorphins Sales Value by Type
  11. 4.3.1 Global Endorphins Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Endorphins Sales Value by Type (2021-2032)
  13. 4.3.3 Global Endorphins Sales Value Share by Type (2021-2032)
5 Endorphins Market by Application
  1. 5.1 Endorphins Application Introduction
  2. 5.1.1 Institutional Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Online Pharmacies
  5. 5.2 Global Endorphins Sales Volume by Application
  6. 5.2.1 Global Endorphins Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Endorphins Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Endorphins Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Endorphins Sales Value by Application
  10. 5.3.1 Global Endorphins Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Endorphins Sales Value by Application (2021-2032)
  12. 5.3.3 Global Endorphins Sales Value Share by Application (2021-2032)
6 Endorphins Regional Sales and Value Analysis
  1. 6.1 Global Endorphins Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Endorphins Sales by Region (2021-2032)
  3. 6.2.1 Global Endorphins Sales by Region: 2021-2026
  4. 6.2.2 Global Endorphins Sales by Region (2027-2032)
  5. 6.3 Global Endorphins Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Endorphins Sales Value by Region (2021-2032)
  7. 6.4.1 Global Endorphins Sales Value by Region: 2021-2026
  8. 6.4.2 Global Endorphins Sales Value by Region (2027-2032)
  9. 6.5 Global Endorphins Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Endorphins Sales Value (2021-2032)
  12. 6.6.2 North America Endorphins Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Endorphins Sales Value (2021-2032)
  15. 6.7.2 Europe Endorphins Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Endorphins Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Endorphins Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Endorphins Sales Value (2021-2032)
  21. 6.9.2 South America Endorphins Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Endorphins Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Endorphins Sales Value Share by Country, 2025 VS 2032
7 Endorphins Country-level Sales and Value Analysis
  1. 7.1 Global Endorphins Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Endorphins Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Endorphins Sales by Country (2021-2032)
  4. 7.3.1 Global Endorphins Sales by Country (2021-2026)
  5. 7.3.2 Global Endorphins Sales by Country (2027-2032)
  6. 7.4 Global Endorphins Sales Value by Country (2021-2032)
  7. 7.4.1 Global Endorphins Sales Value by Country (2021-2026)
  8. 7.4.2 Global Endorphins Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Endorphins Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Endorphins Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Endorphins Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Endorphins Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Endorphins Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Endorphins Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Endorphins Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Endorphins Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Endorphins Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Endorphins Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Endorphins Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Endorphins Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Endorphins Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Endorphins Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Endorphins Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Endorphins Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Endorphins Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Endorphins Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Endorphins Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Endorphins Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Endorphins Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Endorphins Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Endorphins Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Endorphins Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Endorphins Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Endorphins Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Endorphins Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Endorphins Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Endorphins Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Endorphins Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Endorphins Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Endorphins Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Endorphins Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Endorphins Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Endorphins Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Endorphins Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Endorphins Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Endorphins Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Endorphins Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Endorphins Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Endorphins Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Endorphins Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Endorphins Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Endorphins Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Endorphins Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Endorphins Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Endorphins Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Endorphins Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Endorphins Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Endorphins Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Endorphins Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Endorphins Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Endorphins Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Endorphins Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Endorphins Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Endorphins Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Endorphins Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Endorphins Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Endorphins Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Endorphins Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Endorphins Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Endorphins Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Endorphins Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Endorphins Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Endorphins Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Endorphins Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Endorphins Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Endorphins Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Endorphins Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Endorphins Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Endorphins Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Endorphins Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Endorphins Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Endorphins Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Endorphins Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Endorphins Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Endorphins Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Endorphins Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Endorphins Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Endorphins Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Endorphins Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Endorphins Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Endorphins Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Endorphins Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Assertio Therapeutics Inc.
  2. 8.1.1 Assertio Therapeutics Inc. Company Information
  3. 8.1.2 Assertio Therapeutics Inc. Business Overview
  4. 8.1.3 Assertio Therapeutics Inc. Endorphins Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Assertio Therapeutics Inc. Endorphins Product Portfolio
  6. 8.1.5 Assertio Therapeutics Inc. Recent Developments
  7. 8.2 Cipher Pharmaceuticals Inc.
  8. 8.2.1 Cipher Pharmaceuticals Inc. Company Information
  9. 8.2.2 Cipher Pharmaceuticals Inc. Business Overview
  10. 8.2.3 Cipher Pharmaceuticals Inc. Endorphins Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cipher Pharmaceuticals Inc. Endorphins Product Portfolio
  12. 8.2.5 Cipher Pharmaceuticals Inc. Recent Developments
  13. 8.3 Egalet Corp.
  14. 8.3.1 Egalet Corp. Company Information
  15. 8.3.2 Egalet Corp. Business Overview
  16. 8.3.3 Egalet Corp. Endorphins Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Egalet Corp. Endorphins Product Portfolio
  18. 8.3.5 Egalet Corp. Recent Developments
  19. 8.4 Endo International Plc
  20. 8.4.1 Endo International Plc Company Information
  21. 8.4.2 Endo International Plc Business Overview
  22. 8.4.3 Endo International Plc Endorphins Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Endo International Plc Endorphins Product Portfolio
  24. 8.4.5 Endo International Plc Recent Developments
  25. 8.5 Lannett Co. Inc.
  26. 8.5.1 Lannett Co. Inc. Company Information
  27. 8.5.2 Lannett Co. Inc. Business Overview
  28. 8.5.3 Lannett Co. Inc. Endorphins Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lannett Co. Inc. Endorphins Product Portfolio
  30. 8.5.5 Lannett Co. Inc. Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Endorphins Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Endorphins Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Johnson & Johnson
  38. 8.7.1 Johnson & Johnson Company Information
  39. 8.7.2 Johnson & Johnson Business Overview
  40. 8.7.3 Johnson & Johnson Endorphins Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Johnson & Johnson Endorphins Product Portfolio
  42. 8.7.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Endorphins Value Chain Analysis
  2. 9.1.1 Endorphins Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Endorphins Sales Mode & Process
  6. 9.2 Endorphins Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Endorphins Distributors
  9. 9.2.3 Endorphins Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst